News

Read the latest news and updates.

2020 PRiME Fellowship Awards

1 September 2020

The second cohort of PRiME Fellows was announced today, with nine exceptional young scientists receiving funding to conduct impactful research at the University of Toronto. Their projects focus on diagnostic or therapeutic solutions that will tackle a variety of diseases, ranging from fibrosis to COVID-19, using approaches in molecular biology, genomics, computational biology, and bioengineering. […]

PRiME’s Industry-Partnered Fellowship Program Launches With COVID-19 Projects

Many of the trainees working with PRiME faculty members will pursue career opportunities in the life sciences sector and value the opportunity to collaborate with industry groups during their time at UofT. To create internships with industry partners for PRiME trainees, a new Fellowship Program was launched in July that will provide a framework to […]

Catching Up with the Inaugural 2019 PRiME Fellows

Last September, the first annual PRiME Fellowship Awards were presented to 10 outstanding trainees at the University of Toronto to drive forward high-risk, multidisciplinary research focused on solutions in precision medicine. Projects ranged from innovations in drug discovery to diagnostic development and improving our understanding of disease biology. As we approach the end of our […]

PRiME COVID-19 Task Force convenes second mini-symposium

With the first half of 2020 coming to a close, and the world still struggling with the COVID-19 pandemic, efforts to rapidly develop novel diagnostics and therapeutics continue both worldwide and locally. On June 23rd, the PRiME COVID-19 Task Force on Advanced Diagnostics and New Therapeutics held a second mini-symposium to share the latest research […]

Start-ups founded by PRiME members attract major pharmaceutical interest

Start-up companies co-founded by PRiME faculty members, Sachdev Sidhu and Jason Moffat, have garnered the attention of major pharmaceutical partners, with several acquisitions transpiring over the last month. Earlier this week, Gilead Sciences purchased a stake in Pionyr Immunotherapeutics for $275M to access its Myeloid TuningTM approach to cancer immunotherapies. The technology, which is based […]

Join PRiME in the 40th Anniversary of Terry Fox's Marathon of Hope

In celebration of the extraordinary life of Terry Fox and the 40th anniversary of his Marathon of Hope, the PRiME team will be participating in the virtual 2020 Terry Fox Run: One Day, Your Way on Sunday, September 20th, to raise much needed funds for cancer research. PRiME faculty members bring a diverse range of […]

PRiME COVID-19 Task Force holds its first mini-symposium

Following its launch at the end of March, members of the PRiME COVID-19 Task Force on Advanced Diagnostics and New Therapeutics have been actively working on projects for novel diagnostics and therapeutics to help combat the pandemic here in Canada. While we couldn’t provide an in-person forum to hear about the progress being made, we […]

PRiME announces a COVID-19 Task Force on Advanced Diagnostics and New Therapeutics

As the global community responds to the COVID-19 pandemic, PRiME is convening its leading researchers to form a COVID-19 Task Force on Advanced Diagnostics and New Therapeutics to develop an arsenal of breakthroughs to fight COVID-19 and future pandemics. UofT researchers who are leading experts in disease biology, medicinal chemistry, device engineering, pharmaceutical sciences, and […]

PRiME Faculty Awarded Research Funding to Address COVID-19

PRiME faculty members Dev Sidhu and Keith Pardee are among the select researchers awarded federal grant funding to address the coronavirus disease (COVID-19) outbreak. The two projects highlight the novel treatments and diagnostics being developed by researchers within the PRiME community. In an emergency call for applications, the Canadian Institutes of Health Research (CIHR), in […]

PRiME's First Trainee Collaboration Event

28 February 2020

View fullsize PRiME’s Director, Shana Kelley, often gets asked by students how ideas behind her many collaborations started and believes that informal brainstorming with people from other fields is key. While PRiME’s cross-disciplinary membership brings together an ideal community for these types of conversations, we wanted to give our trainees a focused opportunity to brainstorm […]

PRiME Featured at the Globe and Mail Biotech Innovation Summit

26 November 2019

On November 14th, the Globe and Mail hosted the Biomedical Innovation Summit, sponsored by Novo Nordisk. The half-day event focused on how to grow Canada’s strengths in the biomedical sector and included keynote presentations from Jason Field, President & CEO of Life Sciences Ontario (LSO) and Michael Hyatt, a technology investor and entrepreneur. PRiME’s Director, […]

PRiME's first Research Retreat

14 November 2019

As one can imagine, with over 50 faculty members and close to 100 trainees in our community, getting everyone together is not easy. However, on November 5th, we had an impressive turnout at our first internal research retreat. It was encouraging to see this engagement from our community, especially with several scientific conferences, upcoming grant […]

← View newer posts 1 2 3 4 5 View older posts →